• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

For Primary Prevention, Should All Moderate- to High-Risk Patients Be Considered Candidates for Acetylsalicylic Acid?

出版信息

Can J Hosp Pharm. 2020 Jan-Feb;73(1):58-61. Epub 2020 Feb 1.

PMID:32109962
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7023933/
Abstract
摘要

相似文献

1
For Primary Prevention, Should All Moderate- to High-Risk Patients Be Considered Candidates for Acetylsalicylic Acid?对于一级预防，所有中高危患者都应被视为乙酰水杨酸的适用对象吗？
Can J Hosp Pharm. 2020 Jan-Feb;73(1):58-61. Epub 2020 Feb 1.
2
[Acetylsalicylic acid for the primary prevention of cardiovascular disease in diabetic patients].[乙酰水杨酸用于糖尿病患者心血管疾病的一级预防]
Ned Tijdschr Geneeskd. 2004 Jul 24;148(30):1481-5.
3
[Acetylsalicylic acid in patients with diabetes mellitus: can be used for secondary but not primary prevention of cardiovascular events].糖尿病患者使用乙酰水杨酸：可用于心血管事件的二级预防，但不能用于一级预防
Ned Tijdschr Geneeskd. 2009;153:A109.
4
[No role for oral anticoagulants (target INR: 2.0-3.0) after transient ischaemic attack or cerebral infarction of arterial origin; the 'European/Australasian stroke prevention in reversible ischaemia trial' (ESPRIT)].[短暂性脑缺血发作或动脉源性脑梗死之后口服抗凝剂（目标国际标准化比值：2.0 - 3.0）无作用；“欧洲/澳大利亚可逆性缺血性卒中预防试验”（ESPRIT）]
Ned Tijdschr Geneeskd. 2008 Feb 23;152(8):445-53.
5
Design of Randomized, double-blind, Evaluation in secondary Stroke Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate vs. acetylsalicylic acid in patients with Embolic Stroke of Undetermined Source (RE-SPECT ESUS).不明来源栓塞性卒中患者二级预防中比较口服凝血酶抑制剂达比加群酯与阿司匹林疗效及安全性的随机、双盲评估研究（RE-SPECT ESUS）设计
Int J Stroke. 2015 Dec;10(8):1309-12. doi: 10.1111/ijs.12630. Epub 2015 Sep 30.
6
The Impact of Moderate-Dose Acetylsalicylic Acid in the Reduction of Inflammatory Cytokine and Prevention of Complication in Acute Phase of Kawasaki Disease: The Benefit of Moderate-Dose Acetylsalicylic Acid.中等剂量乙酰水杨酸对川崎病急性期炎症细胞因子减少及并发症预防的影响：中等剂量乙酰水杨酸的益处
Children (Basel). 2020 Oct 16;7(10):185. doi: 10.3390/children7100185.
7
[Primary prevention of cardiovascular disease with acetylsalicylic acid: in high-risk patients].[乙酰水杨酸用于心血管疾病的一级预防：高危患者]
Ned Tijdschr Geneeskd. 2005 Apr 16;149(16):853-4.
8
Personalized allocation of acetylsalicylic acid therapy for secondary prevention of coronary artery disease.用于冠状动脉疾病二级预防的阿司匹林治疗的个体化分配
Front Cardiovasc Med. 2022 Sep 27;9:1004473. doi: 10.3389/fcvm.2022.1004473. eCollection 2022.
9
Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland.芬兰的冠心病和外周动脉疾病抗栓治疗的成本效益分析。
Adv Ther. 2020 Jul;37(7):3348-3369. doi: 10.1007/s12325-020-01398-8. Epub 2020 Jun 9.
10
Comparison of antiplatelet regimens in secondary stroke prevention: a nationwide cohort study.二级卒中预防中抗血小板治疗方案的比较：一项全国性队列研究。
BMC Neurol. 2015 Nov 2;15:225. doi: 10.1186/s12883-015-0480-4.

本文引用的文献

1
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial.依度沙班与维生素 K 拮抗剂在房颤患者成功经皮冠状动脉介入治疗后抗栓治疗方案的比较（ENTRUST-AF PCI）：一项随机、开放标签、3b 期临床试验。
Lancet. 2019 Oct 12;394(10206):1335-1343. doi: 10.1016/S0140-6736(19)31872-0. Epub 2019 Sep 3.
2
Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.心房颤动合并稳定性冠心病的抗栓治疗。
N Engl J Med. 2019 Sep 19;381(12):1103-1113. doi: 10.1056/NEJMoa1904143. Epub 2019 Sep 2.
3
The rise and fall of aspirin in the primary prevention of cardiovascular disease.阿司匹林在心脑血管疾病一级预防中的兴衰。
Lancet. 2019 May 25;393(10186):2155-2167. doi: 10.1016/S0140-6736(19)30541-0.
4
Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials.经皮冠状动脉介入治疗的心房颤动患者抗栓策略的安全性和疗效：随机对照试验的网络荟萃分析。
JAMA Cardiol. 2019 Aug 1;4(8):747-755. doi: 10.1001/jamacardio.2019.1880.
5
Aspirin for Primary Prevention of Cardiovascular Events.阿司匹林用于心血管疾病一级预防
J Am Coll Cardiol. 2019 Jun 18;73(23):2915-2929. doi: 10.1016/j.jacc.2019.03.501.
6
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2019 ACC/AHA 心血管疾病一级预防指南：执行摘要：美国心脏病学会/美国心脏协会临床实践指南工作组的报告。
J Am Coll Cardiol. 2019 Sep 10;74(10):1376-1414. doi: 10.1016/j.jacc.2019.03.009. Epub 2019 Mar 17.
7
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.心房颤动急性冠状动脉综合征或经皮冠状动脉介入治疗后的抗血栓治疗。
N Engl J Med. 2019 Apr 18;380(16):1509-1524. doi: 10.1056/NEJMoa1817083. Epub 2019 Mar 17.
8
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2019美国心脏病学会/美国心脏协会心血管疾病一级预防指南：美国心脏病学会/美国心脏协会临床实践指南工作组报告
Circulation. 2019 Sep 10;140(11):e596-e646. doi: 10.1161/CIR.0000000000000678. Epub 2019 Mar 17.
9
Online decision aids for primary cardiovascular disease prevention: systematic search, evaluation of quality and suitability for low health literacy patients.用于原发性心血管疾病预防的在线决策辅助工具：系统检索、质量评估及对健康素养低的患者的适用性
BMJ Open. 2019 Mar 13;9(3):e025173. doi: 10.1136/bmjopen-2018-025173.
10
Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Meta-analysis.阿司匹林用于一级预防与心血管事件及出血事件的相关性：系统评价和荟萃分析。
JAMA. 2019 Jan 22;321(3):277-287. doi: 10.1001/jama.2018.20578.